CSO Christophe Roos discusses clinical application of NGS in Medical Laboratory Observer
Next-generation sequencing, with other technologies, is enabling the emergence of nucleic acid -based testing in the clinical lab. The article in
EMQN & UK NEQAS quality assessment scheme seeks to improve NGS in diagnostic labs
Euformatics’ partners EMQN and UK NEQAS for Molecular Genetics are currently developing the 2016 quality assessment, which NGS labs will be able
Euformatics offers training at the ELIXIR EXCELERATE CSC course on variant interpretation
This ELIXIR EXCELERATE course, organised by CSC, covers several aspects of variant analysis including variant annotation and prioritisation.
EMQN, UK NEQAS for Molecular Genetics, and Euformatics gear up for EQA 2016 Pilot
The team from UK NEQAS for Molecular Genetics and the European Molecular Genetics Quality Network EMQN visited Euformatics to prepare for this
EMQN, UK NEQAS for Molecular Genetics, and Euformatics talk about standardising NGS quality control at ESHG
NGS External Quality Assessment Participants Meeting at ESHG 2016 At the joint UK NEQAS for Molecular Genetics and EMQN Participants meeting the
Euformatics CSO Christophe Roos talks to GenomeWeb
On the heels of the announcement about the CE mark for Euformatics’ omnomicsNGS tool for genome variant interpretation, Christophe addresses
Euformatics receives CE mark for omnomicsNGS
Euformatics has received CE Marking for omnomicsNGS, a tool that helps labs interpret genetic variants and make clinical decisions. The tool can
